Likewise, in HNSCC, a recent study indicated that LINC00052 sponged miR-608 to control epidermal growth factor receptor (EGFR) expression, thereby encouraging advancement both in vitro and in vivo35. Here, EGFR is linked to head and neck squamous cell carcinoma.